News and Trends 9 Feb 2017 Alma Bio Therapeutics is Aiming to Revolutionize the Treatment of IBD A new immune modulator to treat Inflammatory Bowel Diseases (IBD) is the lead asset in development at Alma Bio Therapeutics. We had the opportunity to meet up with the company’s… February 9, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Weekly Roundup 10 Nov 2023 Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs …are small molecules that eliminate disease-causing extracellular proteins, which are drivers of many human diseases, ranging from inflammatory conditions to neurodegenerative diseases to several cancers. Gate’s small molecules bind to… November 10, 2023 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2022 Deep Science Ventures and AbbVie to create companies to target inflammatory diseases Deep Science Ventures (DSV), a London-based venture creator, is teaming up with AbbVie, a global pharmaceutical company, to build one or more new companies targeting immune-mediated inflammatory diseases. Together, the… November 28, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Podcast 1 Dec 2023 Ipsen drug gives hope for liver disease patients On the podcast this week, we are looking at recent advances in treating certain liver diseases. Jennifer Schranz is senior vice president and global head of rare diseases in the… December 1, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2018 Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease Spanish researchers have developed a way to diagnose neurodegenerative diseases by analyzing eye movements. The Madrid-based research team and its spin-off company Aura Innovative Robotics have developed a diagnostic test… June 14, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2022 New company formed to boost life sciences in Singapore …and more accurate outcomes in molecular diagnostics across a wide range of diseases including infectious diseases, neurodegenerative diseases and cancer. It aims to improve lives by providing clarity and accessibility… September 15, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2017 Record Momentum for European Biotech …market in Europe Geneuro, for example, is a Swiss company that focuses on diseases of the nervous system and autoimmune diseases. In 2016, it raised €33m (~ $39m) after its… September 4, 2017 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Infographics by Merck 15 Nov 2021 Gene therapy: Making Rare Disease Therapies Less Rare …therapies for patients with rare diseases. More than 70% of rare diseases are known to be caused by a single mutation, which makes them good candidates for gene therapy. Several… November 15, 2021 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 29 Aug 2022 Marketing authorization granted for treatment of serious retinal diseases The European Commission has granted marketing authorization to Ranivisio, a treatment for several serious retinal diseases. Polpharma Biologics Group BV, Formycon AG and their Swiss joint venture, Bioeq AG, announced… August 29, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 21 Oct 2016 New Partnership comes to the Rescue in Neurological Diseases Developing effective treatments for neurological diseases is a big challenge in medicine. But here come UCB and Evotec with a new partnership that could help those suffering from epilepsy and… October 21, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Podcast 6 Oct 2023 Beyond Biotech podcast 66 – treating rare diseases with tRNA …are harnessing the unique biology of tRNAs to engineer a single tRNA medicine that could treat thousands of rare diseases that share the same genetic mutation. This year, Alltrna presented… October 6, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Oct 2017 Interview: On the Future of iPS Cells and why Partnering is so Important in this Field …own defective cells. The second is in the broader field of drug discovery. Here, iPS cells are being used to explore the underlying causes of human diseases at a molecular… October 16, 2017 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email